BIOMAT Database Logo BIOMAT Database Logo

Experimental kidney disease induced by a puromycin aminonucleoside. 1960

A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D009401 Nephrosis Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA. Nephroses
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D011692 Puromycin Aminonucleoside PUROMYCIN derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties and can cause nephrosis. 3'-Amino-3'-deoxy-N,N-dimethyladenosine,Aminonucleoside,3' Amino 3' deoxy N,N dimethyladenosine,Aminonucleoside, Puromycin

Related Publications

A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
July 1983, Journal of pharmacobio-dynamics,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat.
January 2012, American journal of nephrology,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins.
April 1980, Experimental and molecular pathology,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Teratogenic effect of puromycin aminonucleoside on rat kidney.
January 1966, Nephron,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Reduced kidney branched chain aminotransferase expression in puromycin aminonucleoside-induced nephrotic syndrome.
January 1997, Life sciences,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
[Establishment of a podocyte cell injury model induced by puromycin aminonucleoside].
December 2008, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Role of bad in podocyte apoptosis induced by puromycin aminonucleoside.
March 2013, Transplantation proceedings,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
The effect of puromycin and aminonucleoside on kidney proteins.
September 1970, Canadian journal of biochemistry,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
February 1982, The Journal of clinical investigation,
A MERCHANTE, and R ORTEGA, and H CASTRO, and C JIMENEZ DIAZ
Sinkihwan-gamibang ameliorates puromycin aminonucleoside-induced nephrotic syndrome.
March 2022, Chinese journal of natural medicines,
Copied contents to your clipboard!